Coreline Soft Shares Global Commercialization Strategy for Medical AI at DHP 2026
Coreline Soft, a South Korean medical artificial intelligence (AI) company, shared its global commercialization strategy, highlighting how technologies and operational experience gained through Korea's national lung cancer screening program are supporting its expansion into international healthcare markets.The company announced that CEO Jin Kook Kim participated as a speaker at "DHP 2026:…
Coreline Soft, a South Korean medical artificial intelligence (AI) firm, detailed its global expansion plan at DHP 2026: Breakout to the Globe, a digital healthcare summit held in Seoul. The two-day event, organized by venture capital firm Digital Healthcare Partners, featured 37 speakers from tech firms and healthcare entities worldwide.
Coreline Soft CEO Jin Kook Kim addressed the audience on the first day, discussing how the company's national lung cancer screening program's technological and operational learnings are paving the way for international markets, particularly in Germany and France. Kim stressed that successful AI integration into healthcare systems hinges on seamless incorporation into existing workflows and radiologists' interpretation processes.
The company's strategy emphasizes adapting AI technologies to meet the operational demands of national screening programs and healthcare providers.
Written by urgent.news from Korea IT Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
